Browse by category

Journal watch 27/11/2024

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Liraglutide after RYGB results in significant weight loss and resolution of obesity-related conditions

Adjunctive use of liraglutide at a dose of 3mg/day with conversional Roux-en-Y Gastric Bypass (cRYGB) results in significant weight loss,...

Discovery of Neuropeptide Y could lead to simpler and cheaper drugs to control obesity and weight gain

An international team of researchers has discovered a new component of the peripheral nervous system that acts by increasing energy...

Study examines California's legislative efforts on obesity and finds critical insights into policy trends and success rates over two decades

A recent multi-campus study, co-led by public health researchers from University of California (UC) Irvine and UC Merced, is the first of...

Allurion launches AllurionMeds first AI-native compounded GLP-1 program

Allurion Technologies has launched AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss...

COMBINE trial: Glucose clamp technique as part of a new type 2 diabetes research trial

Researchers at Leicester Diabetes Centre (LDC) have successfully started using the glucose clamp technique as part of a new type 2...

Laekna and Eli Lilly to develop ActRIIA antibody for muscle-preserving weight loss in obesity

Laekna Therapeutics has entered a clinical collaboration with Eli Lilly to accelerate the development of LAE102, a novel Activin Receptor...

More than half of US adults could benefit from GLP-1 medications

More than half of US adults, an estimated that 137 million people, are eligible for semagludtide for weight loss, diabetes management, or...

BMS safe and effective for patients living with severe obesity

Bariatric and metabolic surgery (BMS) is largely safe and effective for patients who are living with severe obesity, according to a team...

GLP-1 RAs found to shrink heart muscle in mice and human cells

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with shrinking the human heart and other muscles, according to a...

1 2

4 5

Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler

2 days ago

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

5 days ago

Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes

6 days ago

Browse by category

Browse by tag

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net